Opt countries, sites and investigators for your clinical trial.
Analyzing the feasibility of clinical trials and selecting appropriate sites and investigators is a crucial aspect of effective trial planning. Utilizing high-quality data to determine your country-site-PI strategy is arguably the most significant factor in achieving enrollment targets within expected timelines and obtaining the necessary results for endpoint evaluation.
Shen takes pride in offering a solution that facilitates the entire process of feasibility and site selection, including insights from clinical trial landscapes, site and investigator track records, and knowledge of relevant patient populations for your protocol.
See how we prioritize data in your decision-making process and provide support in delivering a trial that stays on schedule and within budget, minimizing the need for costly and avoidable protocol amendments or site expansions.
Perform feasibility assessments and choose sites and investigators that set your trial on a successful course
As protocols grow in complexity, and the pool of available patients remains limited due to rising competition among trials, the choice of sites and investigators can determine the success or failure of your trial. How can you guarantee that your selections maximize your trial’s likelihood of success?
A widely recognized platform for site and investigator intelligence, when paired with an exceptional trials database, can provide invaluable insights.
Perform thorough feasibility analysis with benchmarking available across a database of over 400,000 trials.
Identify sites and investigators with experience recruiting similar patient populations.
Evaluate country selection with a significant number of sites/investigators with relevant experience.
Analyze patients targeted by competing trials.
Integrate data into your own systems through an API.
Explore tailored consulting projects such as “feasibility as a service,” utilizing real-world data to pinpoint sites with protocol-aligned patients.
Shen offers a full end-to-end drug development process
Hailed throughout the industry as the leading resources for protocol optimization, feasibility analysis, and site-investigator selection, Shen doesn’t stop there.
We offer support at every step of the drug development journey, from preclinical stages and commercial activities to licensing, patient engagement, recruitment, and regulatory submissions.
Products and services that are pertinent
Pharmaceutical Initiatives
Certainly, here’s a more SEO-friendly version:
With a robust database comprising over 90,000 drug profiles, including 20,000 in active development, Pharmaprojects stands as the industry standard for tracking and analyzing the global drug research and development (R&D) landscape. It serves as the trusted reference for the global drug R&D industry pipeline, offering a comprehensive view from preclinical stages to product launch.
- Explore the competitive landscape
- Support business development (BD) and licensing initiatives
- Stay updated on vital market trends
Perfection is not a final stop; it is an enduring expedition
Excellence is not a fixed destination that we reach and then become complacent. It’s a mindset, a way of life that propels us to improve continually. It’s an unwavering commitment to lifelong learning, innovation, and consistently delivering exceptional results.
At our core, we believe that excellence is a collaborative endeavor. We actively seek partnerships and collaborations with esteemed experts, research institutions, and industry trailblazers.
Our team is deeply ingrained in a culture of continuous learning and improvement. We actively encourage our staff to stay at the forefront of industry advancements, constantly seek new knowledge, and embrace emerging technologies and methodologies. This commitment ensures that we remain a leader in our field, delivering the best possible solutions to our clients.
